ConductScience.org, home

Paper36763530

The human proton pump inhibitors inhibit Mycobacterium tuberculosis rifampicin efflux and macrophage-induced rifampicin tolerance.

Lake MA and 11 others. Proc Natl Acad Sci U S A, 2023. Cited by 26 papers, by iCite.

Cite this record

ConductScience Library. The human proton pump inhibitors inhibit Mycobacterium tuberculosis rifampicin efflux and macrophage-induced rifampicin tolerance. Papers, record 36763530. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36763530

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The human proton pump inhibitors inhibit Mycobacterium tuberculosis rifampicin efflux and macrophage-induced rifampicin tolerance.
PubMed
Journal
Proc Natl Acad Sci U S A
PubMed
Year
2023
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
26
iCite
Relative citation ratio, by iCite
3.33
iCite
Revised in PubMed
2025-07-20
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lake MAM Alexandrahttps://orcid.org/0000-0003-3265-0078
2Adams KNKristin N
3Nie FFeilin
4Fowler EElaine
5Verma AKAmit K
6Dei SSilvia
7Teodori EElisabetta
8Sherman DRDavid R
9Edelstein PHPaul Hhttps://orcid.org/0000-0002-4069-5279
10Spring DRDavid Rhttps://orcid.org/0000-0001-7355-2824
11Troll MMark
12Ramakrishnan LLalitahttps://orcid.org/0000-0003-0692-5533

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Mycobacterium tuberculosisMajor topic
TuberculosisMajor topic
Humans
Rifampin
Proton Pump Inhibitors
Antitubercular Agents
Verapamil
Macrophages
Drug Tolerance
Bacterial Proteins
Microbial Sensitivity Tests

Source PubMed

Download CSV of topics

Grants10

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
U19 AI162598NIAID NIH HHSUnited StatesU19AI162598PubMed and NIHNIH RePORTER
211145/Z/18/ZWellcome TrustUnited KingdomPubMedPubMed
223103Wellcome TrustUnited KingdomPubMedPubMed
U19 AI135976NIAID NIH HHSUnited StatesU19AI135976PubMedNIH RePORTER
R01 AI146194NIAID NIH HHSUnited StatesR01AI146194PubMed and NIHNIH RePORTER
R37 AI054503NIAID NIH HHSUnited StatesR01AI054503PubMed and NIHNIH RePORTER
R01 AI054503NIAID NIH HHSUnited StatesR01AI054503PubMed and NIHNIH RePORTER
R01 AI150826NIAID NIH HHSUnited StatesR01AI150826PubMedNIH RePORTER
223103/Z/21/ZWellcome TrustUnited KingdomPubMedPubMed
R37AI054503NIHNIH RePORTER

Download CSV of grants

References103

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135737799Tumor necrosis factor induces pathogenic mitochondrial ROS in tuberculosis through reverse electron transport.Science2022https://conductscience.org/library/papers/35737799PubMed
219325113Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding.Science2009https://conductscience.org/library/papers/19325113PubMed
316279802Exploratory chemistry toward the identification of a new class of multidrug resistance reverters inspired by pervilleine and verapamil models.J Med Chem2005https://conductscience.org/library/papers/16279802PubMed
428201528Pharmacoepidemiology for nephrologists: do proton pump inhibitors cause chronic kidney disease?Nephrol Dial Transplant2017https://conductscience.org/library/papers/28201528PubMed
521332993Ethidium bromide transport across Mycobacterium smegmatis cell-wall: correlation with antibiotic resistance.BMC Microbiol2011https://conductscience.org/library/papers/21332993PubMed
623245571New structure-activity relationship studies in a series of N,N-bis(cyclohexanol)amine aryl esters as potent reversers of P-glycoprotein-mediated multidrug resistance (MDR).Bioorg Med Chem2013https://conductscience.org/library/papers/23245571PubMed
718770603Genetic Manipulation of Mycobacterium tuberculosis.Curr Protoc Microbiol2007https://conductscience.org/library/papers/18770603PubMed
817416489Permeation of permanently positive charged molecules through artificial membranes--influence of physico-chemical properties.Eur J Pharm Sci2007https://conductscience.org/library/papers/17416489PubMed
922232275Functional and genetic characterization of the tap efflux pump in Mycobacterium bovis BCG.Antimicrob Agents Chemother2012https://conductscience.org/library/papers/22232275PubMed
1032974492Cell wall inhibitors increase the accumulation of rifampicin in Mycobacterium tuberculosis.Access Microbiol2019https://conductscience.org/library/papers/32974492PubMed
1111557355Structure-activity relationships and optimisation of the selective MDR modulator 2-(3,4-dimethoxyphenyl)-5-(9-fluorenylamino)-2-(methylethyl) pentanenitrile and its N-methyl derivative.Bioorg Med Chem2001https://conductscience.org/library/papers/11557355PubMed
1235263517Shorter Treatment for Nonsevere Tuberculosis in African and Indian Children.N Engl J Med2022https://conductscience.org/library/papers/35263517PubMed
1312068801Mystery of multidrug transporters: the answer can be simple.Mol Microbiol2002https://conductscience.org/library/papers/12068801PubMed
1431152740Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin.Gastroenterology2019https://conductscience.org/library/papers/31152740PubMed
1521376383Drug tolerance in replicating mycobacteria mediated by a macrophage-induced efflux mechanism.Cell2011https://conductscience.org/library/papers/21376383PubMed
1612121966Resazurin microtiter assay plate: simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis.Antimicrob Agents Chemother2002https://conductscience.org/library/papers/12121966PubMed
1733951360Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis.N Engl J Med2021https://conductscience.org/library/papers/33951360PubMed
1826980498Morphological changes and differentially expressed efflux pump genes in Mycobacterium tuberculosis exposed to a rifampicin and verapamil combination.Tuberculosis (Edinb)2016https://conductscience.org/library/papers/26980498PubMed
1930920070The association between proton pump inhibitor use and the risk of tuberculosis: A case-control study.Pharmacoepidemiol Drug Saf2019https://conductscience.org/library/papers/30920070PubMed
2018310137Thioridazine and chlorpromazine inhibition of ethidium bromide efflux in Mycobacterium avium and Mycobacterium smegmatis.J Antimicrob Chemother2008https://conductscience.org/library/papers/18310137PubMed

See all 103 referencesDownload CSV of references

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.

PMIDTitleJournalYearIn PapersSource
42708030Beyond acid suppression: the multifaceted role of proton pump inhibitors in Helicobacter pylori eradication.Front Microbiol2026https://conductscience.org/library/papers/42708030PubMed
42344733CRISPRi-mediated silencing of the ABC transporter Ms_5779 compromises cell envelope integrity and impairs intracellular host lipid exploitation.Front Microbiol2026https://conductscience.org/library/papers/42344733PubMed
42038188Comparison of Energy and Frequency of Nanosecond Q-switched ND-YAG Laser and Chlorhexidine on Reducing the Number of Oral Streptococcus Mutans Isolates: In Vitro Study :.Galen Med J2025https://conductscience.org/library/papers/42038188PubMed
41961393Integrated computational and experimental approaches for drug repurposing targeting key Mycobacterium tuberculosis proteins.Mol Divers2026https://conductscience.org/library/papers/41961393PubMed
41303606Verapamil Suppresses the Development of Resistance Against Anti-Tuberculosis Drugs in Mycobacteria.Int J Mol Sci2025https://conductscience.org/library/papers/41303606PubMed
40697410A potent phenylalkylamine disrupts mycobacterial membrane bioenergetics and augments bactericidal activity of bedaquiline.iScience2025https://conductscience.org/library/papers/40697410PubMed
40572115Antimicrobial and Anti-Efflux Machinery of FDA-Approved Proton Pump Inhibitors and Vitamins Against Klebsiella pneumoniae and Pseudomonas aeruginosa.Microorganisms2025https://conductscience.org/library/papers/40572115PubMed
40331858Bedaquiline does not enhance a clofazimine-azithromycin-ethambutol regimen against Mycobacterium avium in the hollow-fiber system.Antimicrob Agents Chemother2025https://conductscience.org/library/papers/40331858PubMed
40244664Verapamil and its metabolite norverapamil inhibit the Mycobacterium tuberculosis MmpS5L5 efflux pump to increase bedaquiline activity.Proc Natl Acad Sci U S A2025https://conductscience.org/library/papers/40244664PubMed
39446300Molecular Indicator for Distinguishing Multi-drug-Resistant Tuberculosis from Drug Sensitivity Tuberculosis and Potential Medications for Treatment.Mol Biotechnol2025https://conductscience.org/library/papers/39446300PubMed
39364170A virulence-associated small RNA MTS1338 activates an ABC transporter CydC for rifampicin efflux in Mycobacterium tuberculosis.Front Microbiol2024https://conductscience.org/library/papers/39364170PubMed
39315396Photothermal and host immune activated therapy of cutaneous tuberculosis using macrophage targeted mesoporous polydopamine nanoparticles.Mater Today Bio2024https://conductscience.org/library/papers/39315396PubMed
39219694Enhance the Antimycobacterial Activity of Streptomycin with Ebselen as an Antibiotic Adjuvant Through Disrupting Redox Homeostasis.Drug Des Devel Ther2024https://conductscience.org/library/papers/39219694PubMed
37983978A Dose-Finding Study to Guide Use of Verapamil as an Adjunctive Therapy in Tuberculosis.Clin Pharmacol Ther2024https://conductscience.org/library/papers/37983978PubMed
37834390Drug-Tolerant Mycobacterium tuberculosis Adopt Different Survival Strategies in Alveolar Macrophages of Patients with Pulmonary Tuberculosis.Int J Mol Sci2023https://conductscience.org/library/papers/37834390PubMed
37256924Profile of Lalita Ramakrishnan.Proc Natl Acad Sci U S A2023https://conductscience.org/library/papers/37256924PubMed
36951140Redefining tuberculosis: an interview with Lalita Ramakrishnan.Dis Model Mech2023https://conductscience.org/library/papers/36951140PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ABCB15243PubTator's text mininghttps://conductscience.org/library/genes/5243NCBI Gene
ABCB610058PubTator's text mininghttps://conductscience.org/library/genes/10058NCBI Gene
FLNB2317PubTator's text mininghttps://conductscience.org/library/genes/2317NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36763530

GET https://conductscience.org/api/papers/v1/36763530/references?page=2